Edition:
United States

Diagnos Inc (ADK.V)

ADK.V on TSX Venture Exchange

0.14CAD
17 Nov 2017
Change (% chg)

$0.01 (+8.00%)
Prev Close
$0.12
Open
$0.13
Day's High
$0.14
Day's Low
$0.12
Volume
589,000
Avg. Vol
479,012
52-wk High
$0.20
52-wk Low
$0.05

Latest Key Developments (Source: Significant Developments)

Diagnos says ‍cardiovascular artery disease prevention score development six to twelve months ahead of schedule
Tuesday, 19 Sep 2017 09:00am EDT 

Sept 19 (Reuters) - Diagnos Inc :Diagnos - ‍cardiovascular artery disease prevention score development six to twelve months ahead of schedule; commercial launch in first half of 2018​.  Full Article

Diagnos announces restatement of March 31, 2017 financial statements which resulted in a decrease in expenses of $2,491,096
Monday, 28 Aug 2017 03:34pm EDT 

Aug 28 (Reuters) - Diagnos Inc :Diagnos announces restatement of March 31, 2017 financial statements which resulted in a decrease in expenses of $2,491,096.Diagnos - ‍restatement resulted in a comprehensive loss of $2.8 million, basic diluted comprehensive loss per share of $0.02 for year ended March 31, 2017​.  Full Article

Diagnos inc announces signature of new $4.16 million contract with Government Of Mexico
Monday, 17 Jul 2017 10:33am EDT 

July 17 (Reuters) - Diagnos Inc ::Diagnos Inc - announced on July 17 signature of a new contract valued at $4.16 million usd with Government Of Mexico.Says contract awarded after completion of successful pilot program covering 79,407 patients.  Full Article

Diagnos says divesting mining division
Wednesday, 15 Mar 2017 09:00am EDT 

Diagnos Inc : Diagnos, in a strategic move, is divesting its mining division to focus on detection of critical health issues through the use of its artificial intelligence platform .Diagnos -under terms of agreement, on or before March 31, Majescor will issue 8 million shares to diagnos at $0.10 per share, in payment for assets acquired.  Full Article

BRIEF-Diagnos Inc signs one-year screening contract in North Africa​

* Diagnos Inc - "‍positive conclusion" to a pilot project by signing a turnkey one-year screening contract in North Africa​ Source text for Eikon: Further company coverage: